News

Each year, landmarks, homes, and communities across the country light up in red to honor those affected by amyloidosis and to raise awareness of this rare disease.…

AbstractBackgroundAcquired transthyretin (ATTR) amyloidosis is increasingly reported among domino liver transplantation (DLT) recipients who receive livers from…

Accurate differentiation between light-chain (AL) amyloidosis and transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) is critical for effective patient…

Accurate differentiation between light-chain (AL) amyloidosis and transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) is critical for effective patient…

Northfield, Ill. (November 24, 2025) — A new evidence-based guideline to help standardize the diagnosis of amyloidosis and improve patient care, was just published…

Key TakeawaysATTR-CM is a rare heart failure type caused by transthyretin protein buildup, leading to heart muscle thickening and symptoms such as shortness of…

Accurate differentiation between light-chain (AL) amyloidosis and transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) is critical for effective patient…

The objective of this study is to determine the association of clinically prescribed, on-label, TTR stabilizing therapy (e.g. tafamidis or acoramidis) with levels…

Long trips can be stressful, especially when you’re living with a rare disease like amyloidosis. Symptoms vary from person to person, and the disease can affect…

Key TakeawaysAmyloidosis can cause balance problems in several ways, including nerve damage, low blood pressure, and fatigue, which can make everyday activities…